Literature DB >> 16879865

Controlled release of sirolimus from a multilayered PLGA stent matrix.

Xintong Wang1, Subbu S Venkatraman, Freddy Y C Boey, Joachim S C Loo, Lay Poh Tan.   

Abstract

The release of sirolimus from a bi-layer biodegradable polymeric film is reported in this study. Approved drug-eluting metal stents use a thin polymer coating to control drug release, but the degree of control is limited. In a fully polymeric stent, the use of multilayers allows a range of release kinetics. A bi-layer system, with PLLA as the supporting layer and PLGA as the drug-eluting layer, was used in this study to simulate release of sirolimus from a stent. The results show that the release of sirolimus is diffusion and degradation-controlled, and that the amount of sirolimus loading does not affect its release kinetics. The release of sirolimus is, however, accelerated by the addition of a plasticizer, such as PEG, as water uptake is increased. An increased water uptake increases polymer degradation, and changes the dominant mode of release to degradation-control. The release of sirolimus can, on the other hand, be retarded by using a coating of a biodegradable polyester with a lauryl ester end group. Therefore, multilayered systems offer many options for controlling sirolimus release over months.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879865     DOI: 10.1016/j.biomaterials.2006.07.016

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  23 in total

Review 1.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

Review 2.  Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems.

Authors:  Yao Fu; Weiyuan John Kao
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Accelerated endothelialization with a polymer-free sirolimus-eluting antibody-coated stent.

Authors:  Zhanjiang Yu; Huagang Zhu; Shuzheng Lü; Xiaoda Yang
Journal:  J Mater Sci Mater Med       Date:  2013-08-23       Impact factor: 3.896

4.  CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic co-glycolic acid) microparticles and films.

Authors:  E Y Chen; S Chu; L Gov; Y K Kim; M B Lodoen; A J Tenner; W F Liu
Journal:  J Mater Chem B       Date:  2017-01-10       Impact factor: 6.331

5.  Electrospun rapamycin-eluting polyurethane fibers for vascular grafts.

Authors:  Jingjia Han; Shady Farah; Abraham J Domb; Peter I Lelkes
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

6.  Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery.

Authors:  Xiaoxiang Zhu; Richard D Braatz
Journal:  J Biomech Eng       Date:  2014-11       Impact factor: 2.097

7.  A mechanistic model for drug release in PLGA biodegradable stent coatings coupled with polymer degradation and erosion.

Authors:  Xiaoxiang Zhu; Richard D Braatz
Journal:  J Biomed Mater Res A       Date:  2014-11-12       Impact factor: 4.396

8.  Paclitaxel distribution in poly(ethylene glycol)/poly(lactide-co-glycolic acid) blends and its release visualized by coherent anti-Stokes Raman scattering microscopy.

Authors:  Eunah Kang; Joshua Robinson; Kinam Park; Ji-Xin Cheng
Journal:  J Control Release       Date:  2007-05-17       Impact factor: 9.776

Review 9.  Recent advances in drug eluting stents.

Authors:  Amey S Puranik; Eileen R Dawson; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2012-10-29       Impact factor: 5.875

10.  Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.

Authors:  Filis Kazazi-Hyseni; Mariana Landin; Audrey Lathuile; Gert J Veldhuis; Sima Rahimian; Wim E Hennink; Robbert Jan Kok; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2014-05-14       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.